EU CE Mark and MDR Historically, getting a CE mark and bringing a product to market in the EU was seen as straightforward, predictable, and the preferred geography to launch a product initially. Does the MDR change this perception? Why or why not? You may want to consider the U.S. FDA framework and trends in […]
Tag Archives: scrutiny
